Arnold L Oronsky's Net Worth
$452 Million
Who is Arnold L Oronsky?
Arnold L Oronsky has an estimated net worth of $452 Million. This is based on reported shares across multiple companies, which include EnteroMedics Inc, INTRALASE CORP, Invuity, Inc., Trius Therapeutics Inc, GLAUKOS Corp, Eiger BioPharmaceuticals, Inc., KalVista Pharmaceuticals, Inc., Marketo, Inc., OBALON THERAPEUTICS INC, Venus Concept Inc., Transcept Pharmaceuticals Inc, EPOCRATES INC, METABASIS THERAPEUTICS INC, AVEDRO INC, DYNAVAX TECHNOLOGIES CORP, ANESIVA, INC., PMV Pharmaceuticals, Inc., MACROGENICS INC, TESARO, Inc., APPLIED GENETIC TECHNOLOGIES CORP, MYOGEN INC, and CORIXA CORP.
SEC CIK
Arnold L Oronsky's CIK is 0001207833
Past Insider Trading and Trends
2014 was Arnold L Oronsky's most active year for acquiring shares with 39 total transactions. Arnold L Oronsky's most active month to acquire stocks was the month of May. 2005 was Arnold L Oronsky's most active year for disposing of shares, totalling 45 transactions. Arnold L Oronsky's most active month to dispose stocks was the month of October. 2007 saw Arnold L Oronsky paying a total of $9,500,001.45 for 3,552,070 shares, this is the most they've acquired in one year. In 2013 Arnold L Oronsky cashed out on 40,770,500 shares for a total of $70,818,664.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EnteroMedics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +724.94% | 1.36M |
—
|
—
| 1.55M |
Nov 20
| |||
Form 4
|
∞
| 187.5K |
$8.00 | $1,500,000.00 | 187.5K |
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
INTRALASE CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -49.64% | -1.68M |
—
|
—
| 1.71M |
Jun 7
| |||
Form 4
|
∞
| 3.39M |
—
|
—
| 3.39M |
Oct 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Invuity, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.08M |
—
|
—
| 1.08M |
Jun 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Trius Therapeutics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.55M |
$4.77 |
—
| 3.55M |
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GLAUKOS Corp (GKOS) Snapshot price: $94.715
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.6M |
—
|
—
| 2.6M |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |